Opinion

The challenges of implementing ePRO – part two

Having worked in the electronic patient reported outcomes (ePRO) industry for a number of years, Scimcon’s Head of ePRO and eClinical Services Dave Sanders knows a thing or two about ePRO implementation. Dave has helped to implement strategies to roll out ePRO into clinical studies across multiple therapeutic areas. In the second instalment of our two-part series, we will be looking at some of the further challenges associated with ePRO, and how to overcome them.

Read More >

The evolution of pharmacovigilance

Pharmacovigilance (PV) has big changes coming in the form of disruptive technology. Organisational structures and responsibilities must adapt to respond to current and projected changes to business needs. Here, industry leader Jamie Portnoff shares her thoughts and experience of PV with us.

Read More >

The challenges of implementing ePRO – part one

Having worked in the electronic patient reported outcomes (ePRO) industry for a number of years, helping to implement a strategy to roll out ePRO into clinical studies across multiple therapeutic areas, Scimcon’s Head of ePRO and eClinical Services Dave Sanders knows a thing or two about ePRO implementation. Here, he reflects on some of the challenges we have encountered, and how we overcame those challenges, in the first instalment of our two-part blog series.

Read More >
In order to work as intended, this site stores cookies on your device. Accepting improves our site and provides you with personalized service.
Click here to learn more